THRAP3 interacts with HELZ2 and plays a novel role in adipocyte differentiation

Molecular Endocrinology

Volumn 27, Issue 5, 2013, Pages 769-780

  Katano Toki, Akiko ^a   Satoh, Tetsurou ^a   Tomaru, Takuya ^a   Yoshino, Satoshi ^a   Ishizuka, Takahiro ^a   Ishii, Sumiyasu ^a   Ozawa, Atsushi ^a   Shibusawa, Nobuyuki ^a   Tsuchiya, Takafumi ^a   Saito, Tsugumichi ^a   Shimizu, Hiroyuki ^a   Hashimoto, Koshi ^a   Okada, Shuichi ^a   Yamada, Masanobu ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; FAT DROPLET; FATTY ACID BINDING PROTEIN 4; HELICASE WITH ZINC FINGER 2 BETA; KRUPPEL LIKE FACTOR 5; MEDIATOR COMPLEX; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BCL 2; SMALL INTERFERING RNA; THYROID HORMONE RECEPTOR ASSOCIATED PROTEIN 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2; TROGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRAIN 3T3; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; ENHANCER REGION; ENZYME ACTIVATION; GENE ACTIVATION; GENE SILENCING; GENETIC TRANSCRIPTION; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; AMINO ACID MOTIFS; ANIMALS; CELL DIFFERENTIATION; CHROMATOGRAPHY, LIQUID; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICE; NUCLEAR PROTEINS; PPAR GAMMA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; RESPONSE ELEMENTS; RNA HELICASES; RNA-BINDING PROTEINS;

EID: 84876874503     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1332     Document Type: Article

References (51)

1. Glass CK. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev. 1994;15: 391-407.
2. Ribeiro RC, Kushner PJ, Baxter JD. The nuclear hormone receptor gene superfamily. Annu Rev Med. 1995;46:443-453.
3. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000;14:121-141.
4. Lonard DM, Lanz RB, O'Malley BW. Nuclear receptor coregulators and human disease. Endocr Rev. 2007;28:575-587.
5. Lonard DM, O'Malley BW. Nuclear receptor coregulators: modulators of pathology and therapeutic targets. Nat Rev Endocrinol. 2012;8:598-604.
6. Caelles C, González-Sancho JM, Muñoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 1997;11:3351-3364.
7. Desai-Yajnik V, Hadzic E, Modlinger P, Malhotra S, Gechlik G, Samuels HH. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator. J Virol. 1995;69:5103-5112.
8. Lee Y, Nadal-Ginard B, Mahdavi V, Izumo S. Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene. Mol Cell Biol. 1997;17:2745-2755.
9. Pfitzner E, Kirfel J, Becker P, Rolke A, Schüle R. Physical interaction between retinoic acid receptor and the oncoprotein myb inhibits retinoic acid-dependent transactivation. Proc Natl Acad Sci USA. 1998;95:5539-5544.
10. Qi JS, Desai-Yajnik V, Yuan Y, Samuels HH. Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression. Mol Cell Biol. 1997;17:7195-7207.
11. Ishizuka T, Satoh T, Monden T, et al. Human immunodeficiency virus type 1 Tat binding protein-1 is a transcriptional coactivator specific for TR. Mol Endocrinol. 2001;15:1329-1343.
12. Satoh T, Ishizuka T, Tomaru T, et al. Tat-binding protein-1 (TBP-1), an ATPase of 19S regulatory particles of the 26S proteasome, enhances androgen receptor function in cooperation with TBP-1-interacting protein/Hop2. Endocrinology. 2009;150:3283-3290.
13. Satoh T, Ishizuka T, Yoshino S, et al. Roles of proteasomal 19S regulatory particles in promoter loading of thyroid hormone receptor. Biochem Biophys Res Commun. 2009;386:697-702.
14. Lehrke M, Lazar MA. The many faces of PPARgamma. Cell. 2005; 123:993-999.
15. Michalik L, Auwerx J, Berger JP, et al. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev. 2006;58:726-741.
16. Siersbaek R, Nielsen R, Mandrup S. PPARgamma in adipocyte differentiation and metabolism-novel insights from genome-wide studies. FEBS Lett. 2010;584:3242-3249.
17. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92:829-839.
18. Louet JF, O'Malley BW. Coregulators in adipogenesis: what could we learn from the SRC (p160) coactivator family? Cell Cycle. 2007; 6:2448-2452.
19. Koppen A, Kalkhoven E. Brown vs white adipocytes: the PPARγ coregulator story. FEBS Lett. 2010;584:3250-3259.
20. Tomaru T, Satoh T, Yoshino S, et al. Isolation and characterization of a transcriptional cofactor and its novel isoform that bind the deoxyribonucleic acid-binding domain of peroxisome proliferatoractivated receptor-γ. Endocrinology. 2006;147:377-388.
21. Surapureddi S, Yu S, Bu H, et al. Identification of a transcriptionally active peroxisome proliferator-activated receptor γ-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator. Proc Natl Acad Sci USA. 2002;99:11836-11841.
22. Fondell JD, Ge H, Roeder RG. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci USA. 1996;93:8329-8333.
23. Malik S, Roeder RG. Transcriptional regulation through Mediatorlike coactivators in yeast and metazoan cells. Trends Biochem Sci. 2000;25:277-283.
24. Tagaya Y, Miura A, Okada S, Ohshima K, Mori M. Nucleobindin-2 is a positive modulator of EGF-dependent signals leading to enhancement of cell growth and suppression of adipocyte differentiation. Endocrinology. 2012;153:3308-3319.
25. Oh I S, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443:709-712.
26. Guan HP, Ishizuka T, Chui PC, Lehrke M, Lazar MA. Corepressors selectively control the transcriptional activity of PPARγ in adipocytes. Genes Dev. 2005;19:453-461.
27. Lefebvre B, Benomar Y, Guédin A, et al. Proteasomal degradation of retinoid X receptor γ reprograms transcriptional activity of PPARγ in obese mice and humans. J Clin Invest. 2010;120:1454-1468.
28. Sarras H, Alizadeh Azami S, McPherson JP. In search of a function for BCLAF1. ScientificWorld J. 2010;10:1450-1461.
29. Tontonoz P, Hu E, Spiegelman BM. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γ. Curr Opin Genet Dev. 1995;5:571-576.
30. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor. Cell. 1994;79:1147-1156.
31. Takahashi N, Kawada T, Yamamoto T, et al. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREBbinding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor γ. J Biol Chem. 2002;277:16906-16912.
32. Mandrup S, Lane MD. Regulating adipogenesis. J Biol Chem. 1997;272:5367-5370.
33. Chen Z, Torrens JI, Anand A, Spiegelman BM, Friedman JM. Krox20 stimulates adipogenesis via C/EBPβ-dependent and-independent mechanisms. Cell Metab. 2005;1:93-106.
34. Oishi Y, Manabe I, Tobe K, et al. Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 2005;1:27-39.
35. Altamura N, Groudinsky O, Dujardin G, Slonimski PP. NAM7 nuclear gene encodes a novel member of a family of helicases with a Zn-ligand motif and is involved in mitochondrial functions in Saccharomyces cerevisiae. J Mol Biol. 1992;224:575-587.
36. Kang YH, Lee CH, Seo YS. Dna2 on the road to Okazaki fragment processing and genome stability in eukaryotes. Crit Rev Biochem Mol Biol. 2010;45:71-96.
37. Agostini M, Schoenmakers E, Mitchell C, et al. Non-DNA binding, dominant-negative, human PPARγ mutations cause lipodystrophic insulin resistance. Cell Metab. 2006;4:303-311.
38. Lee KM, Hsu IW, Tarn WY. TRAP150 activates pre-mRNA splicing and promotes nuclear mRNA degradation. Nucleic Acids Res. 2010;38:3340-3350.
39. Heyd F, Lynch KW. Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing. Mol Cell. 2010;40: 126-137.
40. Beli P, Lukashchuk N, Wagner SA, et al. Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response. Mol Cell. 2012;46:212-225.
41. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006;4:263-273.
42. Siersbæk R, Nielsen R, Mandrup S. Transcriptional networks and chromatin remodeling controlling adipogenesis. Trends Endocrinol Metab. 2012;23:56-64.
43. Lefterova MI, Zhang Y, Steger DJ, et al. PPARγ and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genomewide scale. Genes Dev. 2008;22:2941-2952.
44. Nielsen R, Pedersen TA, Hagenbeek D, et al. Genome-wide profiling of PPARγ:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXRdimer composition during adipogenesis. Genes Dev. 2008;22: 2953-2967.
45. Wakabayashi K, Okamura M, Tsutsumi S, et al. The peroxisome proliferator-activated receptor γ/retinoid X receptor γ heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol Cell Biol. 2009;29:3544-3555.
46. Steger DJ, Grant GR, Schupp M, et al. Propagation of adipogenic signals through an epigenomic transition state. Genes Dev. 2010; 24:1035-1044.
47. Ge K, Guermah M, Yuan CX, et al. Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. Nature. 2002;417:563-567.
48. Ge K, Cho YW, Guo H, et al. Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor β-stimulated adipogenesis and target gene expression. Mol Cell Biol. 2008;28:1081-1091.
49. Grøntved L, Madsen MS, Boergesen M, Roeder RG, Mandrup S. MED14 tethers mediator to the N-terminal domain of peroxisome proliferator-activated receptor gamma and is required for full transcriptional activity and adipogenesis. Mol Cell Biol. 2010;30:2155-2169.
50. Wang W, Huang L, Huang Y, et al. Mediator MED23 links insulin signaling to the adipogenesis transcription cascade. Dev Cell. 2009; 16:764-771.
51. Mishra A, Zhu XG, Ge K, Cheng SY. Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms. J Mol Endocrinol. 2010;44:247-255.